Kolexia
Borg Christophe Oncologie médicale
Borg Christophe
Oncologie médicale
Hôpital Nord Franche-Comté
Montbéliard, France
458 Activités
5 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs colorectales Carcinomes Adénocarcinome Métastase tumorale Tumeurs du foie Tumeurs du rectum Tumeurs du pancréas Carcinome épidermoïde Tumeurs de l'estomac

Collaborateurs

Voir plus
Jary Marine
Jary Marine
Hôpital Estaing, Clermont-Ferrand, France
Ghiringhelli Francois
Ghiringhelli Francois
Centre Georges-François Leclerc, Dijon, France
Bouche Olivier
Bouche Olivier
Hôpital Robert-Debré Reims, Reims, France
Adotevi Olivier
Adotevi Olivier
Hôpital Jean-Minjoz, Besançon, France

Industries

Voir plus
MSD
16 collaboration(s)
Dernière en 2023
Servier
14 collaboration(s)
Dernière en 2023
Bayer
13 collaboration(s)
Dernière en 2023
Amgen
8 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
MOUNTAINEER-03: An Open-label Randomized Phase 3 Study of Tucatinib in Combination With Trastuzumab and mFOLFOX6 Versus mFOLFOX6 Given With or Without Either Cetuximab or Bevacizumab as First-line Treatment for Subjects With HER2+ Metastatic Colorectal Cancer
Essai Clinique (Seagen)   15 mars 2024
innovaTV 207: Open Label Phase 2 Study of Tisotumab Vedotin for Locally Advanced or Metastatic Disease in Solid Tumors
Essai Clinique (Seagen)   15 mars 2024
SCARCE: A Non-comparative Randomized 2:1 Phase II Study of Docetaxel, Cisplatin, and 5-fluorouracil in Combination or Not With Atezolizumab in Patients With Metastatic or Unresectable Locally Advanced Squamous Cell Anal Carcinoma
Essai Clinique (Roche)   08 mars 2024
iintune-1: An Open-label, Dose Escalation, Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-676 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced or Metastatic Solid Tumors
Essai Clinique (Takeda Pharmaceutical)   07 mars 2024
HERIZON-GEA-01: A Randomized, Multicenter, Phase 3 Study of Zanidatamab in Combination With Chemotherapy With or Without Tislelizumab in Subjects With HER2-positive Unresectable Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma (GEA)
Essai Clinique (Jazz Pharmaceuticals)   04 mars 2024
FIGHT: A Phase 2 Randomized, Double-Blind, Controlled Study Evaluating Bemarituzumab (FPA144) and Modified FOLFOX6 in Patients With Previously Untreated Advanced Gastric and Gastroesophageal Junction Cancer: Phase 2 Preceded by Dose-Finding in Phase 1
Essai Clinique (Five Prime Therapeutics, Inc.)   23 février 2024
TASKIN: Multicentric Randomized Phase I/II Study to Evaluate Efficacy of Trifluridine/Tipiracil Plus XB2001 (Anti-IL-1α True Human Antibody) Versus Trifluridine/Tipiracil Plus Placebo in Metastatic Colorectal Cancer Patients After Failure of Oxaliplatin, Irinotecan, Fluoropyrimidine
Essai Clinique (Centre Georges-François Leclerc)   12 février 2024
PREDICT-IRFC: Exploratory Study of the Relevance of a Blood Test in the Management of Patients in the Context of Colorectal Cancer Screening
Essai Clinique (CHU Besançon)   07 février 2024
CLIMES: Circulating Tumor DNA in Patients With Colorectal Cancer Undergoing Curative-intent Surgery for Liver Metastases: Prospective, Multicenter, GERCOR Cohort
Essai Clinique (GERCOR (Multidisciplinary Group in Oncology))   02 février 2024
CIRCA-HPV: Circulating Tumor DNA for the Early Detection of HPV-positive Pelvic Cancer Relapses
Essai Clinique (Institut Curie)   29 janvier 2024